首页 > 资料专栏 > 组织 > 机构类型 > 门店及网点 > 【医疗行业研报】摩根士丹利_中国医疗保健行业_零售药店:追求规模和经营效率_2022年.1.17_54页PDF

【医疗行业研报】摩根士丹利_中国医疗保健行业_零售药店:追求规模和经营效率_2022年.1.17_54页PDF

鼎盛今日
V 实名认证
内容提供者
资料大小:4664KB(压缩后)
文档格式:PDF(56页)
资料语言:中文版/英文版/日文版
解压密码:m448
更新时间:2023/10/16(发布于北京)
阅读:6
类型:金牌资料
积分:--
推荐:升级会员

   点此下载 ==>> 点击下载文档


“【医疗行业研报】摩根士丹利_中国医疗保健行业_零售药店:追求规模和经营效率_2022年.1.17_54页PDF”第1页图片 “【医疗行业研报】摩根士丹利_中国医疗保健行业_零售药店:追求规模和经营效率_2022年.1.17_54页PDF”第2页图片 图片预览结束,如需查阅完整内容,请下载文档!
文本描述
MFoundationJanuary 17, 2022 01:43 AM GMTAsia Primer: China HealthcareRetail Pharmacies – In Pursuit ofScale and Operational EfficiencyAs distributors' growth slows, market focus is shifting downstream to the relatively less-developed but fast-growing retail pharmacy segment. In this report, we delve into thepolicy drivers, market dynamics, business models, and top players, all the while drawingparallels with the US and Japan.Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict ofinterest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investmentdecision.For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.+= Analysts employed by non-U.S. affiliates are not registered with FINRA, may not be associated persons of the member and may not be subject to FINRA restrictions oncommunications with a